Shares of Novavax (NASDAQ:NVAX) jumped on Tuesday on news of a major supply deal with the Japanese government. By the close of trading, the biotechnology company’s stock price was up 7.6%.
Japan’s Ministry of Health, Labour, and Welfare will buy 150 million doses of Novavax’s COVID-19 vaccine candidate, subject to regulatory approval. The financial terms of the agreement were not disclosed.
Novavax struck a sizable coronavirus vaccine supply deal with Japanese health officials. Image source: Getty Images.
Top 5 Biotech....More>>>
Having dropped from the lofty heights it reached only a few short months ago, Alector (NASDAQ:ALEC) stock was having another bad day on Wednesday. The biotech’s shares were down nearly 17% in mid-afternoon trading following some news from the C-suite.
After market hours on Tuesday, Alector announced the departure of two high-level executives. It said that chief operating officer Shehnaaz Suliman and chief medical officer Robert Paul will step down following a “transition period,” and should continue to serve as advisors to the company....More>>>
Shares of Moderna (NASDAQ:MRNA) jumped 7.8% on Thursday after the drugmaker announced several notable advances during its annual research and development update.
Moderna is developing a single-dose vaccine, known as mRNA-1073, that includes boosters against both COVID-19 and seasonal flu. The biotech is also evaluating four development candidates against coronavirus variants, including Delta, with three already in clinical trials.
Moderna’s stock price rose sharply following its R&D update on Thursday. Image source: Getty Images.
One of this week’s top roller-coaster stocks, biotech Impel NeuroPharma (NASDAQ:IMPL), experienced another queasy price lurch on Friday. The company’s shares fell by almost 24% on the pricing of an upcoming share issue.
After market hours on Thursday, Impel NeuroPharma set the price for its previously announced 3 million-share issue of common stock at $15 per share. The company is also granting the issue’s underwriters a 30-day option to buy up to an additional 450,000 shares at that price. The issue should close next Tuesday, Sept.....More>>>
Apple has picked Sept. 14 as the date for its annual product launch, where the tech giant is expected to introduce the iPhone 13. Other product models, including the Apple Watch Series 7 and AirPods 3, may also make their debuts.
The date came in a tweet from Greg Joswiak, Apple’s senior vice president of marketing. Joswiak wrote “We’re California Streaming on September 14th. See you real soon. #AppleEvent,” and posted a 17-second video that starts with the Apple logo and ends with “9.14.”
Shares of Apple (ticker: AAPL) climbed 1.6% Tuesday, while....More>>>